Oxidation of debrisoquine by marmoset CYP2D enzymes, CYP2D19 and CYP2D30

被引：0
|
作者：
Narimatsu, S
Kuramoto, S
Hichiya, H
Yamamoto, S
Asaoka, K
Miyata, A
Kiryu, K
Ueda, N
Naito, S
Ellis, SW
机构：
[1] Okayama Univ, Fac Pharmaceut Sci, Lab Hlth Chem, Okayama, Japan
[2] Okayama Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Okayama, Japan
[3] Kyoto Univ, Primate Res Inst, Dept Mol Physiol, Aichi, Japan
[4] Kagoshima Univ, Sch Med, Dept Pharmacol, Kagoshima 890, Japan
[5] Otsuka Pharmaceut Factory Inc, Res & Dept, Tokushima, Japan
[6] Univ Sheffield, Sect Mol Pharmacol & Pharmacogenet, Sheffield, S Yorkshire, England
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
384
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [1] Structure and function of a novel CYP2D enzyme, CYP2D30 from marmoset liver: Comparison with CYP2D19
    Hichiya, H
    Kuramoto, S
    Yamamoto, S
    Asaoka, K
    Miyata, A
    Narimatsu, S
    DRUG METABOLISM REVIEWS, 2003, 35 : 104 - 104
  • [2] Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19
    Hichiya, H
    Kuramoto, S
    Yamamoto, S
    Shinoda, S
    Hanioka, N
    Narimatsu, S
    Asaoka, K
    Miyata, A
    Iwata, S
    Nomoto, M
    Satoh, T
    Kiryu, K
    Ueda, N
    Naito, S
    Tucker, GT
    Ellis, SW
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (01) : 165 - 175
  • [3] Debrisoquine Metabolism and CYP2D Expression in Marmoset Liver Microsomes
    Cooke, Brian R.
    Bligh, S. W. Annie
    Cybulski, Z. Richard
    Ioannides, Costas
    Hall, Michael
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 70 - 75
  • [4] Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19
    Narimatsu, Shizuo
    Nakata, Toshiyuki
    Shimizudani, Takeshi
    Nagaoka, Kenjiro
    Nakura, Hironori
    Masuda, Kazufumi
    Katsu, Takashi
    Koeda, Akiko
    Naito, Shinsaku
    Yamano, Shigeru
    Miyata, Atsuro
    Hanioka, Nobumitsu
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 189 (03) : 146 - 152
  • [5] In situ hybridization study of CYP2D mRNA in the common marmoset brain
    Shimamoto, Yoshinori
    Niimi, Kimie
    Kitamura, Hiroshi
    Tsubakishita, Sae
    Takahashi, Eiki
    EXPERIMENTAL ANIMALS, 2016, 65 (04) : 465 - 471
  • [6] CYP2D is involved in neurosteroidogenesis in the brain
    Kishimoto, W
    Hiroi, T
    Osada, M
    Imaoka, S
    Igarashi, T
    Fuane, Y
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 223 - 225
  • [7] The endogenous substrates of brain CYP2D
    Wang, Xiaoshuang
    Li, Jie
    Dong, Guicheng
    Yue, Jiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 211 - 218
  • [8] Expression and localisation of CYP2D enzymes in rat basal ganglia
    Riedl, AG
    Watts, PM
    Edwards, RJ
    Schulz-Utermoehl, T
    Boobis, AR
    Jenner, P
    Marsden, CD
    BRAIN RESEARCH, 1999, 822 (1-2) : 175 - 191
  • [9] Localisation of CYP2D enzymes in naive rat basal ganglia
    Riedl, AG
    Brown, CT
    Rose, S
    Schulz-Utermoehl, T
    Edwards, RJ
    Boobis, AR
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U132 - U132
  • [10] DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS AND POSSIBLE SUSCEPTIBILITY TO SCHIZOPHRENIA
    VALLADA, H
    COLLIER, D
    DAWSON, E
    OWEN, M
    NANKO, S
    MURRAY, R
    GILL, M
    LANCET, 1992, 340 (8812): : 181 - 182
12345